AnaSpecs Offers Dyes for labeling Amine- and Thiol-Modified Oligos
December 9, 2010
AnaSpec is pleased to highlight our own proprietary HiLyte Fluor dyes for labeling amine and thiol modified oligonucleotides from AnaSpec’s wide collection of amine and thiol reactive 6-isomeric dyes of fluoresceins and rhodamines. Fluorescent dye-labeled oligos are widely used as primers for sequencing and PCR reactions, and also as probes for fluorescence in situ hybridization [...]
December 9, 2010
Second Task Order Received Under U.S. Government ID/IQ Award Valued Up to $67.0 Million BILLERICA, Mass. - American Science and Engineering, Inc. ("AS&E") (NASDAQ:ASEI), a leader in X-ray detection technology, announced that the Company has been awarded an additional order valued at $4.9 million under the indefinite delivery, indefinite quantity (ID/IQ) contract from the U.S. [...]
Hamilton Thorne Launches Groundbreaking Stiletto™ laser system
December 9, 2010
Reduces Manual Laboratory Research Processes from Hours to Seconds; Saving Significant Time and Money BEVERLY, MA and TORONTO, Ontario - Hamilton Thorne Ltd. (TSX-V: HTL), a leading provider of advanced laser systems for the regenerative medicine and stem cell research markets, today announced the launch of its new Stiletto™ laser system. The Stiletto™ laser system [...]
WaferGen Expands Scientific Advisory Board with Appointment of Industry Leader Dr. Timothy J. Triche
December 9, 2010
Fremont, Calif. - WaferGen Biosystems, Inc. (OTCBB:WGBS), a leading developer of state-of-the-art genomic analysis systems, today announced that it has named industry leader Timothy J. Triche, M.D., Ph.D., Professor of Pathology and Pediatrics at the University of Southern California (USC) Keck School of Medicine, as a member of the company’s Scientific Advisory Board. “Dr. Triche, [...]
Fitch Rates Life Technologies’ Proposed Unsecured Notes ‘BBB-‘; Outlook Stable
December 9, 2010
NEW YORK - Fitch Ratings has assigned a 'BBB-' rating to Life Technology Corp.'s proposed $600 million unsecured notes. Fitch anticipates that proceeds of the notes offering will be used to refinance existing debt as well as for other general corporate purposes. Fitch currently rates Life Technologies as follows: --Issuer Default Rating (IDR) 'BBB-'; --Senior [...]
Horizon Secures License from Case Western to 35 Endogenously Tagged Human Isogenic Cell Lines
December 9, 2010
Horizon Discovery (Horizon) today announced it has secured worldwide exclusive rights to a panel of new human isogenic cell models developed by Dr. Zhenghe Wang, Assistant Professor of Genetics at Case Western Reserve University School of Medicine, using its proprietary rAAV GENESIS gene-editing platform. The in-licensed lines will be added to Horizon’s rapidly expanding library [...]
Pacific Biosciences and Harvard Scientists Decode Genome of Haitian Cholera Pathogen
December 9, 2010
Menlo Park, Calif. - Scientists from Pacific Biosciences of California, Inc. (NASDAQ: PACB) and Harvard Medical School have successfully employed single molecule, real-time (SMRT™) DNA sequencing technology to rapidly characterize the pathogen responsible for the recent deadly cholera epidemic in Haiti. Published online Thursday in the New England Journal of Medicine, the results provide the [...]
Infinite® 200 PRO Offers Environmental Control for Cell-Based Applications
December 9, 2010
Männedorf, Switzerland - Tecan has launched a Gas Control Module (GCM™) for its Infinite 200 PRO multimode microplate reader, creating one of the most comprehensive solutions on the market for cell-based assays. Variations in environmental conditions can lead to inconsistent and unreliable data for cell-based optical studies, due changes in the pH and color of [...]
Ocimum Closes $8 million to Fuel Future Growth
December 9, 2010
Gaithersburg, Maryland, USA and Hyderabad, Andhra Pradesh, India - Ocimum Biosolutions today announced its growth plans after having closed funding worth $8 million from multiple sources, including founders and existing shareholders, in order to cater to the growing demand for its integrated genomic services and to provide unparalleled, hassle-free user experience by enhancing its RaaS [...]
December 9, 2010
The United States welcomes the policy statement and roadmap issued today by the World Health Organization (WHO) charting the rollout of the Xpert MTB/RIF rapid diagnostic test for tuberculosis (TB) and rifampicin resistance, a proxy for multidrug resistant tuberculosis (MDR-TB). The limitations of traditional smear microscopy, along with the cost and long delays to receive [...]

